SEC Form 5/A · accession 0001611650-15-000001
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Christopher Pearce
Officer — CHIEF OPERATING OFFICER · Director
Period of report
Dec 31, 2014
Accepted (ET)
Oct 15, 2015 · 3:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Nov 25, 2014 | J | 500,000 | $0.00 | D | 1,576,125 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The total number of shares has been adjusted to delete shares inadvertently included in the prior report.